AceLink Therapeutics

Overcome genetic diseases, one at a time

General Information
Company Name
AceLink Therapeutics
Founded Year
2019
Location (Offices)
Newark, United States +1
Founders / Decision Makers
Number of Employees
4
Industries
-
Funding Stage
Series Unknown
Social Media

AceLink Therapeutics - Company Profile

AceLink Therapeutics is a biopharmaceutical startup based in the San Francisco Bay Area, founded in 2019. The company's mission is to develop innovative drugs to combat genetically associated human diseases. Their initial focus is on creating a small molecule drug for polycystic kidney disease (PKD), a condition affecting 12 million patients globally. The recent Venture Round investment on 01 January 2022 attracted funding from Viva BioInnovator, Kaitai Capital, and Xiamen Changrong Investment Management. With a commitment to "overcome genetic diseases, one at a time," AceLink Therapeutics demonstrates potential in addressing unmet medical needs.

Taxonomy: biopharmaceutical, startup, drug development, genetic diseases, small molecule drugs, polycystic kidney disease, San Francisco Bay Area, precision medicine

Funding Rounds & Investors of AceLink Therapeutics (1)

View All
Funding Stage Amount No. Investors Investors Date
Venture Round Unknown 3 01 Jan 2022

Latest News of AceLink Therapeutics

View All

No recent news or press coverage available for AceLink Therapeutics.

Similar Companies to AceLink Therapeutics

View All
Fibrocor Therapeutics - Similar company to AceLink Therapeutics
Fibrocor Therapeutics Targeting Fibrosis Through the Lens of Disease Progression
ReviR Therapeutics - Similar company to AceLink Therapeutics
ReviR Therapeutics Improve human health by Revising drug discovery using RNA and AI technologies
Phialogics - The immune tolerance company - Similar company to AceLink Therapeutics
Phialogics - The immune tolerance company Our R&D platform is focused on developing immune modulating therapeutics for patients with autoimmune diseases.
Kynexis - Similar company to AceLink Therapeutics
Kynexis Kynexis is advancing the first potential precision medicine for the treatment of CIAS.
Bond Biosciences - Similar company to AceLink Therapeutics
Bond Biosciences Discovering and developing first-in-class non-absorbed oral therapeutics to prevent and treat ion-related human diseases